A Study of INCMGA00012 in Squamous Carcinoma of the Anal Canal Following Platinum-Based Chemotherapy (POD1UM-202)

Clinical trial NCT03597295 · COMPLETED

Trial details

NCT number: NCT03597295
Sponsor: Incyte Corporation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of Anal Canal

Start date: 2018-10-08
Primary completion: 2020-06-08
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.